Zaption, a San Francisco based tech startup, is revolutionizing online video for education. Teachers, trainers, and content publishers use Zaption’s intuitive web app to quickly add images, text, quizzes, and discussions to existing videos from YouTube, Vimeo and private video libraries. The result is an interactive learning tour that transforms video from a “lean back” experience to an engaging “lean forward” activity.
As every pharma company invests in digital technology to arm its sales force for more efficient prescriber engagement, MXM Health kicks off a three-part series exploring whether we are overlooking the potential of such techniques for internal...
In a new report, about 63% of surveyed doctors said they were concerned about having gifts they receive from industry groups disclosed on a public database. More than half of those surveyed were unaware of the Physician Payment Sunshine Act.
Absolutely brilliant article on the importance of pharma finally facing the complex and thorny issue of TRUE closed loop marketing, maybe then there will be accurate and informative intelligence and feedback for the new breed of pharma representative.
Assessing how the latest technology trends can support the sales process Mobile, social, Cloud and Big Data are converging, with the sales department seemi. Marketing topic(s):Marketing automation. Advice by Guest Expert.
Seven industry experts evaluate advances and opportunities in nonpersonal promotion to physicians, and debate whether brands really need to deploy sales forces. James Chase chairs the discussion
Dan Baxter's insight:
'Paul Slavin: I agree with you. I don't see reps going away. But, ultimately, it's going to be far more efficient to reach people through technology, through publishing, through content. It's just too efficient for it not to be, as you suggest, the wave of the future.'
Also interesting points about pharma having a greater handle on the data around the operation of the service that your drug plays a part in.
'Strategic Selling moves beyond Solution Selling: it is an even more complex and demanding role based around the ability to proactively identify and position, for the customer, a way forward in the face of a current or imminent business problem, where the customer has yet to identify how to resolve that problem. Indeed, customers may not even realise they have such a problem at the time a true Strategic Salesperson first approaches them.'
Cegedim Relationship Management today announced the release of its thought leadership report, 2012 US Pharma Insights, which provides the results of its third annual survey of life sciences decision makers on current challenges, upcoming business developments, preferred strategies and next generation technology. Leveraging analysis from three years of responses, the report delivers a holistic view of present and future trends.
The Shape of Change in Decision Making, Industry Concerns and the Future
Sustained industry concerns, evolved decision making leadership and new future strategies top 2012’s trends. Aligning with previous years’ responses, 74% of respondents ranked the changing commercial business model as their first, second or third priority of concern; followed by regulatory reform (62%) and market access (53%). Additionally, decision making leadership now sources from executive management for most technology decisions (46%); and strategy/business development for main business model/process changes (55%). Further, respondents clearly defined the following prioritized changes for the near future: increased focus on market access strategies (64%), primary sales force realignment (38%) and increased focus on managed markets (35%).
Boosts in Field Centric Tablet Usage, Preference for Apple® Mobile OS and Noteworthy Social Media Gains
Surveyed executives cite continued focus on field centric tablet usage, their preferred mobile OS and social media. Eight out of ten (80%) currently use or will be using tablets, and unsurprisingly, field sales/account management (61%) account for the most active tablet users. Further, exactly half selected Apple OS as their favorite mobile platform. In terms of social media trending, the report underscores significant increases in usage between 2011 and 2012. LinkedIn (96%) and Facebook (70%) represent respondents’ leading channels with marketing (64%), PR (42%) and sales (38%) make up the most active departments. Lastly, despite minor social media budgets, those surveyed exhibited notable gains according to the report.
“The 2012 US report details exactly how and where our current industry climate is impacting strategy and operations. Respondents report strong focus on business model changes, as well as next generation and mobile technologies,” said Angela Miccoli, President of North America, Cegedim Relationship Management. “In order to further our standing as the leader in pharma CRM, data and compliance solutions, we strive to consistently monitor the pulse of the industry, and empower our customers with our proven insights and expertise.”
'Respondents highlight that tablets are already ingrained in
their companies, but fully leveraging all avenues of this optimal mobile technology will provide the seamless connection between sales forces and today’s evolving business objectives and targets. Tablet-enabled CRM platforms are specifically designed to increase sales efficacy and feature the latest in cloud technology.' <Yet no mention of linking together multichannel marketing strategy?
The future of pharma may look pretty bleak over the next few years. The patent cliff has laid to waste blockbusters while too many drugs that were to replace them have withered on the Phase III trial vine.